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Article abstract 
Objective: To investigate the relationship between leukoaraiosis (LA), which has 
been considered as an intermediate substitute of ischemic brain damages, and 
metabolic syndrome (MetS) that attracts attention as a risk factor for cerebrovascular 
diseases, in healthy subjects derived from various age groups. 
Methods: We studied 1,030 healthy persons at ages between 28 and 78 years (mean, 
52.7 years) with no past history of stroke who visited a health care facility for routine 
health checkups. MetS was defined using the criteria of the National Cholesterol 
Education Program Adult Treatment Panel III. LA was assessed using the rating scale 
of the Atherosclerosis Risk in Communities study on MRI. Logistic regression 
analysis was performed to examine associations between LA and MetS. 
Results: A total of 296 (28.8%) subjects had LA on MRI. MetS was significantly 
associated with the presence of LA [adjusted odds ratio (OR), 3.33; 95% confidence 
interval (CI), 2.30-4.84]. The association was constant across grades of LA; the 
adjusted OR was 3.41 (95%CI, 2.30-5.06) for minimal LA and 3.07 (95%CI, 
1.75-5.38) for LA combining mild, moderate, and severe grades. As for MetS 
components, elevated blood pressure (BP) (adjusted OR,2.16; 95%CI, 1.57 -2.99), 
impaired fasting glucose (IFG) (adjusted OR,1.64; 95%CI, 1.13-2.39), and 
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hypertriglyceridemia (hyper-TG) (adjusted OR,1.56; 95%CI, 1.08-2.28)] were 
independently associated with all grades of LA.  
Conclusions: MetS was significantly associated with every grade of LA, including 
the minimal LA. IFG and hyper-TG were associated with LA independently of 
elevated BP. MetS can play an important role in identifying healthy subjects who 
have an increased risk of LA. 
Key words: cross-sectional study, leukoaraiosis, metabolic syndrome, MRI 
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Introduction 
The term leukoaraiosis (LA) is derived from the Greek leuko (white) and araiosis 
(rarefaction), and refers to lesions of altered signal intensities on CT scans and MRIs 
in the periventricular and subcortical white matter of elderly people.1-4 Traditionally, 
the finding of LA has been considered to have no clinical significance because many 
individuals with LA are asymptomatic1, 2. However, there is accumulating evidence 
from population-based studies that LA is associated with an increased risk of stroke 
and recurrent stroke, depending on the grade of LA that is present.5-7 Furthermore, 
the progression of LA is also significantly associated with cognitive impairments and 
dementia of Alzheimer type.8-12 Thus, LA could be considered as an intermediate 
surrogate of brain dysfunctions including cerebrovascular damages. Prevention of 
occurrence and progress of LA may contribute to avoiding these serious diseases. It 
has been shown that the risk factors for LA are advanced age and elevated blood 
pressure (BP) as well as smoking, alcohol, diabetes, and dyslipidemia.7, 12, 13  These 
risk factors are comparable to those of ischemic heart disease (IHD). A set of 
metabolic and physiological risk factors of IHD, specifically, hypertriglyceridemia 
(hyper-TG), low high-density lipoprotein cholesterol (HDL-C), elevated BP, 
abdominal obesity, and impaired fasting glucose (IFG), has been defined as 
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metabolic syndrome (MetS).14-17 In recent years, MetS has attracted much attention 
as a modifiable condition that increases risks of cerebrovascular events including 
stroke18,19 and silent brain infarction20. However, relationship between MetS and LA 
has been never studied. It is important to elucidate whether MetS increases the risk of 
LA, especially in individuals at middle ages who have not experienced 
cerebrovascular events yet. Most previous studies of LA were targeted on 
populations composed of the older subjects. 2, 4, 6-9 In the present cross-sectional 
study, we examined associations of MetS and its components with LA in healthy 
people at ages from 28 to 78 years. 
Methods 
Study Population.  We studied 1,033 healthy consecutive subjects who, from April 
2005 through March 2006, visited Kochi Healthcare Center (KHC), which is 
affiliated with Kochi Medical School Hospital (KMSH), Kochi prefecture, Japan, 
and underwent a questionnaire survey on medical history and lifestyle, blood 
analysis, and brain MRI as part of their routine health checkup. Three subjects who 
reported that they had a past history of stroke were excluded from this analysis. No 
subject had symptoms or neurological deficits in the physical examination. All 
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subjects lived in Kochi prefecture. A total of 1,030 subjects who satisfied this 
criterion and provided informed consent were included in the study, which was 
approved by the institutional review board at KHC. 
Vascular Risk Factors.  The evaluation of present history of IHD and MetS 
involved data from a questionnaire survey and laboratory results. We used the same 
condition-specific cut points for MetS as those proposed in a recent National 
Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) report, 
with minor modifications. MetS was considered to be present when ≧3 of following 
were met: IFG, elevated BP, hyper-TG, low HDL-C, and abdominal obesity defined 
by a large waist circumference (WC). Specifically, IFG was defined as a fasting 
glucose ≧110 mg/dL and was also considered to be present in persons reporting 
current use of insulin or oral hypoglycemic agents. Elevated BP was defined as a 
systolic BP ≧130 mm Hg or a diastolic BP ≧85 mm Hg; hypertension was also 
considered to be present in persons who reported current use of antihypertensive 
medication. Hyper-TG was determined based on serum triglyceride levels ≧150 
mg/dL. Low HDL-C was identified by a serum HDL-C of <40 mg/dL in men or <50 
mg/dL in women. Hyper-TG or low HDL-C was also considered to be present in 
persons who reported current use of antihyperlipidemia agents. The NCEP-ATP III 
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report defines a large WC as >102 cm in men or >88 cm in women.16 However, these 
cutoff points are not applicable in an Asian population.21 Thus, based on 
recommendations of the Japan Obesity Association, we adopted the definition of a 
large WC as ≧85 cm in men and ≧90 cm in women.22 
LA diagnosis and grading.  MR imaging examinations were performed using 0.4 T 
open MRI (APERTO, Hitachi Medical Corporation, Tokyo, Japan). The imaging 
protocol consisted of: T2-weighted images (repetition time/echo time [TR/TE] 
=5800/105 ms), T1-weighted images (TR/TE=350/13.6 ms), and fluid-attenuated 
inversion recovery (FLAIR; TR/TE=9000/105 ms; inversion time=2200 ms) images. 
Images were obtained as 27 transaxial slices per scan. The slice thickness was 5 mm, 
with no interslice gap. LA was defined as a focal lesion of 3 mm in diameter, with 
hyperintensity on T2-weighted and FLAIR images and without prominent 
hypointensity on TI-weighted images. LA grading was done according to the 
Atherosclerosis Risk in Communities Study (ARIC) as follows.3, 6 no white matter 
signal abnormalities (grade 0); discontinuous periventricular rim or minimal "dots" of 
subcortical white matter (grade 1); thin continuous periventricular rim or few patches 
of subcortical white matter hyperintensity (WMH) (grade 2); thicker continuous 
periventricular rim with scattered patches of subcortical WMH (grade 3); thicker, 
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shaggier periventricular rim with mild subcortical WMH—may have minimal 
confluent PVH (grade 4); mild periventricular confluence surrounding the frontal and 
occipital horns (grade 5); moderate periventricular confluence surrounding the frontal 
and occipital horns (grade 6); periventricular confluence with moderate involvement 
of the centrum semiovale (grade 7); periventricular confluence involving most of the 
centrum semiovale (grade 8); and all white matter involved (grade 9). The ARIC 
MRI standard images were graded 1 through 8: anything less than grade 1 was 
considered grade 0, and anything more than grade 8 was considered grade 9. Finally, 
LA was classified as:none, grade=0; minimal, grades=1-3; mild, grades=4 and 5; 
moderate, grades=6 and 7; and severe, grades=8 and 9. Five trained neurosurgeons 
(KP, ST, SY, HN, and MN) blinded to subject data and diagnosis assessed the 
presence of LA on magnetic resonance images. When the 5 investigators had 
differing opinions, LA classification was determined by consensus.   
Statistical Analysis.  In order to analyze the relationship between study variables 
and LA, we used the chi-square test for categorical data and the Student t-test for 
continuous data that were logarithmically transformed. Multiple logistic regression 
models were fit to determine the associations of MetS and its components with LA 
while controlling for age, gender, present history of IHD, and current smoking as 
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possible confounders. MetS component conditions were included as dichotomous 
variables based on the NCEP-ATP III–defined cut points. Two kinds of regression 
model were fit: model 1 and model 2. In model 1, the component conditions of MetS 
were entered into a model separately; in model 2, five components of MetS were 
entered into a model simultaneously. The model 2 was constructed to examine an 
association between each component and LA when considering interrelationship 
between five components. In particular, because elevated BP is a condition whose 
association with LA has already been established, we thought that it was necessary to 
perform an analysis which addressed confounding effects of elevated BP on the 
associations between other MetS components and LA. A multinomial logistic 
regression model was fit to describe the associations between MetS and different 
categories of LA grades. This single model produced separate odds ratios showing 
associations between MetS and each category of LA grade when none was 
designated as the reference category of LA. Each of the other categories of LA was 
compared with this reference. Three categories of LA greater than or equal to mild, 
i.e., severe, moderate, and mild, were combined due to small numbers of subjects 
with those grades of LA. Age, gender and current smoking were included as 
covariates in the multinomial regression. All P values were 2-tailed, and values of 
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P<0.05 were considered significant. All statistical analyses were performed using 
SPSS14.0 J for Windows (SPSS Japan, Inc., Tokyo).   
Results 
The subjects’ ages ranged from 28 to 78 years; their mean age was 52.7 years. There 
were 534 men and 496 women. As shown in Table 1, on MR imaging of the 1,030 
individuals, minimal LA was found in 205 (19.4%), mild LA in 52 (5.6%), moderate 
LA in 37 (3.6%), and severe LA in 2 (0.2%). LA prevalence increased with ages, 
irrespective of LA grades. Table 2 shows comparisons of elementary statistics of 
study variables between subjects with LA and those without LA. Mean age and the 
proportion of male gender were higher in subjects with LA than in those without LA. 
However, the LA and non-LA groups did not differ with respect to smoking status. 
The prevalence of MetS was significantly higher in the LA group (34.0%) than in the 
non-LA group (13.6%). All MetS components were significantly associated with LA. 
When MetS components were examined individually with adjustment for age, gender, 
present history of IHD, and current smoking (Table 3; model 1), four conditions 
satisfying the NCEP-ATP III–criteria i.e., elevated BP, IFG, hyper-TG, and large WC, 
were associated with increased risks of LA. However, when the five components 
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were entered simultaneously into the model, with adjustment for four covariates 
included in model 1, significant ORs were observed for elevated BP (adjusted OR, 
2.16; 95% CI, 1.57 -2.99), IFG (adjusted OR, 1.64; 95% CI, 1.13-2.39), and 
hyper-TG (adjusted OR, 1.56; 95% CI, 1.08-2.28) (Table 3; model 2). Large WC and 
low HDL-C were not associated with LA in the model 2.  
We examined whether ORs showing the association between LA and MetS increased 
with advancing grades of LA. Mild through severe LA grades were combined into 
one category in this analysis. The proportional odds assumption was checked for the 
relationship between MetS and ordinal categories of LA grades with the test of 
parallel lines under the ordered logistic regression model of LA on dichotomized 
MetS (the location component only model with a logit link function). The null 
hypothesis was rejected that the slope coefficients are the same across categories of 
LA grades (P=0.037). This finding indicates that the proportional odds assumption is 
not reasonable in terms of the relationship between MetS and different categories of 
LA grades. Therefore, a multinomial logistic regression model was used to assess the 
relationship24. As shown in Table 4, the increase in the odds of LA in individuals 
with MetS compared with those without MetS was constant across grades of LA; the 
adjusted ORs were 3.41 (95%CI, 2.30-5.06) for minimal LA, 3.07 (95%CI, 
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1.75-5.38) for mild, moderate, and severe LA, and 3.33 (95%CI, 2.30-4.84) for all 
grades of LA. The adjusted OR for all grades of LA was derived from a multiple 
logistic regression of presence or absence of any grade of LA on presence or absence 
of MetS while considering a set of covariates. 
Discussion 
Several studies have examined the prevalence of LA. The ARIC study reported a 
24.6% prevalence of LA among individuals aged 55-72 years, 49% of whom were 
hypertensives.3 The Cardiovascular Health study found a prevalence of 33% in 
individuals aged 65 years or older, 44% of whom were hypertensives.25 The 
prevalence of LA was 27% in the Rotterdam Study, which included individuals aged 
65-84 years, 39% of whom were hypertensives.9 These prevalence figures were 
obtained without FLAIR images. The prevalence of LA in our study was 28.8% in 
persons aged 28-78 years (Table 1), 37.4% of whom were hypertensives. Given the 
young average age of our study subjects compared with the average ages of other 
study populations, the relatively high prevalence of LA may be due to the accurate 
assessment of minimal LA with FLAIR image of MRI.    
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To the best of our knowledge, the present study provides the information on the 
association between MetS, its components, and LA in healthy people. As shown with 
the model 2 in Table 3, elevated BP was the strongest risk factor of MetS 
components after adjusting for interrelationships among MetS components. 
Furthermore, IFG and hyper-TG were also independent risk factors for LA. The 
association of Hyper-TG with LA has been for the first time described in our study. 
Hyper-TG may be additionally worth exploring as a modifiable factor that may 
contribute to occurrence and development of LA independently of elevated BP.  
LA is a neuroimaging finding that is caused by pathological changes such as 
demyelinization, gliosis, vessel lipohyalinosis, and disturbed blood-brain exchanges.1, 
2, 8 Postmortem studies have indicated that LA seen on MRI are associated with 
degenerative changes in arterioles that are related to atherosclerosis and with 
lipohyalinosis of white matter perforating small arteries.2, 8 Development of ischemic 
injury in white matter substances associated with MetS, whether the pathogenesis is 
atherosclerosis, lipohyalinosis, or both, may be responsible for occurrence and 
development of LA. In the present study, MetS was significantly associated with 
both minimal and advanced LA. This indicates that MetS might be attributable to 
occurrence of LA, but not progression of LA. Specialists and family physicians 
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should note that MetS may be an important factor for occurrence of LA that is 
associated with the development of brain damages such as stroke and dementia. 
When an individual satisfies the criteria on MetS, especially the component 
conditions of elevated BP, IFG or hyper-TG, physicians should also notice the 
possible presence of LA on MRI in spite of the grades. 
The present study was cross-sectional and the causality of the association between 
MetS and LA could not be determined. A longitudinal study that follows the study 
population will provide an opportunity to clarify attributes of MetS and its 
components to occurrence of LA in individuals without LA finding at baseline. 
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None Minimal Mild Moderate Severe All grades
<40 83 96.4 3.6 0 0 0 3.6
40-49 289 87.5 11.8 0.7 0 0 12.5
50-59 417 70.3 22.8 3.6 3.1 0.2 29.7
60-69 193 50.8 27.5 13.0 8.3 0.5 49.2
70<= 48 18.8 31.3 33.3 16.7 0 81.2
Total 1,030 71.2 19.4 5.6 3.6 0.2 28.8
Age group Number
Table 1. Prevalence of leukoaraiosis by age group
Prevalence of grade-specific leukoaraiosis (%)
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(Table 2 continues to the next page.) 
 
 
All
(N=1,030)
Without LA
(N=733)
With LA
(N=297)
P value
Age Mean (SD), years 52.7(9.6) 50.2(8.8) 59.1(8.7) <0.001
Gender Male, Number (%) 534(51.8) 358(48.8) 176(59.3) 0.003
Present history of ischemic heart disease Present, Number (%) 8( 0.8) 6( 0.8) 2( 0.7) >0.900
Current smoking Yes, Number (%) 257(25.0) 174(23.7) 83(27.9) 0.182
Table 2. Vascular risk factors, metabolic syndrome and its components of subjects with/without leukoaraiosis(LA), Part 1
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All
 
(N=1,030)
Without LA
(N=733)
With LA
(N=297)
P value
Metabolic syndrome Present, Number (%) 201(19.5) 100(13.6) 101(34.0) <0.001
Components of metabolic syndrome
 Systolic blood pressure Mean (SD), mmHg 123.1(18.2) 120.1(17.3) 130.5(18.3) <0.001
 Diastolic blood pressure Mean (SD), mmHg 72.6(11.8) 71.3(11.8) 75.6(11.0) <0.001
 Elevated blood pressure Number (%) 385(37.4) 216(29.5) 169(56.9) <0.001
 Fasting blood glucose Mean (SD), mg/dL 103.6(18.7) 102.2(18.6) 107.0(18.4) <0.001
 Impaired fasting glucose Number (%) 228(22.1) 127(17.3) 101(34.0) <0.001
 Triglyceride Mean (SD), mg/dL 119.6(86.0) 113.7(83.1) 133.9(91.4) <0.001
 High-density lipoprotein cholesterol (HDL-C) Mean (SD), mg/dL 67.7(17.8) 68.4(18.1) 65.8(16.8) 0.039
 Hypertriglyceridemia Number (%) 258(25.0) 158(21.6) 100(33.7) <0.001
 Low HDL-C Number (%) 49(4.8) 28(3.8) 21(7.1) 0.040
 Waist circumference Mean (SD), cm 83.0(10.1) 81.9(9.9) 85.7(10.1) <0.001
 Large waist circumference Number (%) 399(38.7) 256(34.9) 143(48.1) <0.001
Table 2. Vascular risk factors, metabolic syndrome and its components of subjects with/without leukoaraiosis(LA), Part 2
 P values were obtained using the chi square test for categorical data, and the t-test for continuous data transformed by logarithm.
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P PComponents of metabolic syndrome value value
Elevated blood pressure, present/absent 2.55 ( 1.87 - 3.48 ) <0.001 2.16 ( 1.57 - 2.99 ) <0.001
Impaired fasting glucose, present/absent 2.23 ( 1.57 - 3.17 ) <0.001 1.64 ( 1.13 - 2.39 ) 0.010
Hypertriglyceridemia, present/absent 1.94 ( 1.37 - 2.73 ) <0.001 1.56 ( 1.08 - 2.28 ) 0.019
Low high-density lipoprotein cholesterol, present/absent 1.75 ( 0.93 - 3.30 ) 0.085 1.07 ( 0.54 - 2.15 ) 0.843
Large waist circumference, present/absent 1.61 ( 1.16 - 2.23 ) 0.005 1.17 ( 0.83 - 1.67 ) 0.370
included in model 1.
Table 3. Adjusted odds ratios (ORs) of leukoaraiosis for components of metabolic syndrome
In model 2, five components were entered into a logistic regression model simultaneously, with adjustment for four covariates
In model 1, separate logistic regression models were fitted for each component, with adjustment for age in years, gender,
Model 2
Adjusted OR(95% CI) Adjusted OR(95% CI)
Model 1
present history of ischemic heart disease, and current smoking.
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ｄ 
 
 
 
 
Grades of leukoaraiosis P value
None 1.00 ( ) -
Minimal 3.41 ( 2.30 - 5.06 ) <0.001
Mild, moderate and severe 3.07 ( 1.75 - 5.38 ) <0.001
All grades 3.33 ( 2.30 - 4.84 ) <0.001
The OR for all grades was obtained by a binary logistic regression model with none as reference.
Both models included age, gender, and current smoking as covariates.
Table 4. Adjusted odds ratios (ORs) of grade-specific leukoaraiosis for metabolic syndrome
Grade-specific ORs were obtained by a multinomial logistic regression model with none as reference.
Adjusted OR(95% CI)
Reference
 
 
 
 
 
 
 
 
 
 
 
 
 
 Park-21
References 
1. Awad IA, Johnson PC, Spetzler RF, Hodak JA. Incidental subcortical lesions 
identified on magnetic resonance imaging in the elderly. II. Postmortem pathological 
correlations. Stroke 1986;17:1090-1097. 
2. Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol 1987;44:21-23. 
3. Liao D, Cooper L, Cai J, Toole JF et al. Presence and severity of cerebral white 
matter lesions and hypertension, its treatment, and its control. The ARIC Study. Stroke 
1996;27:2262-2270. 
4. Goldstein IB, Bartzokis G, Hance DB, Shapiro D. Relationship between blood 
pressure and subcortical lesions in healthy elderly people. Stroke 1998;29:765-772. 
5. Inzitari D, Giordano GP, Ancona AL, Pracucci G, Mascalchi M, Amaducci L. 
Leukoaraiosis, intracerebral hemorrhage, and arterial hypertension. Stroke 1990; 
10:1419-1423. 
6. Wong TY, Klein R, Sharrett AR et al. Cerebral white matter lesions, retinopathy, and 
incident clinical stroke. JAMA 2002;288:67-74. 
7. Jeerakathil T, Wolf PA, Beiser A et al. Stroke risk profile predicts white matter 
hyperintensity volume: the Framingham Study. Stroke 2004;35:1857-1861. 
8. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a 
pathoanatomical study. Ann Neurol 1986;19:253-262. 
 Park-22
9. Breteler MMB, van Swieten JC, Bots ML et al. Cerebral white matter lesions, 
vascular risk factors, and cognitive function in a population-based study: The Rotterdam 
Study. Neurology 1994;44:1246-1252. 
10. De Groot JC, de Leeuw FE, Oudkerk M et al. Periventricular cerebral white matter 
lesions predict rate of cognitive decline. Ann Neurol 2002;52:335-341. 
11. Prins ND, van Dijk EJ, den Heijer T et al. Cerebral white matter lesions and the risk 
of dementia. Arch Neurol 2004;61:1531-1534. 
12. van Dijk EJ, Breteler MM, Schmidt R et al. The association between blood pressure, 
hypertension, and cerebral white matter lesions: cardiovascular determinants of 
dementia study. Hypertension 2004;44:625-630. 
13. den Heijer T, Vermeer SE, van Dijk EJ et al. Alcohol intake in relation to brain 
magnetic resonance imaging findings in older persons without dementia. Am J Clin 
Nutr 2004;80:992-997. 
14. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 
37:1595–1607. 
15. Deedwania PC. The deadly quartet revisited. Am J Med 1998;105(suppl 1A):   
1S–3S.  
16. Executive summary of the third report of the National Cholesterol Education 
Program (NCEP) expert panel on detection, evaluation and treatment of high blood 
cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285:2486–2497. 
 Park-23
17. McNeill AM, Rosamond WD, Girman CJ et al. The metabolic syndrome and 
11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities 
study. Diabetes Care 2005;28:385–390. 
18. Koren-Morag N, Goldbourt U, Tanne D. Relation between the metabolic syndrome 
and ischemic stroke or transient ischemic attack: a prospective cohort study in patients 
with atherosclerotic cardiovascular disease. Stroke 2005;36(7):1366-71. 
19. Bang OY, Kim JW, Lee JH et al. Association of the metabolic syndrome with 
intracranial atherosclerotic stroke. Neurology. 2005 Jul 26;65(2):296-298. 
20. Kwon HM, Kim BJ, Lee SH, Choi SH, Oh BH, Yoon BW. Metabolic syndrome as 
an independent risk factor of silent brain infarction in healthy people. Stroke 
2006;37:466-470. 
21. Western Pacific Regional Office of the World Health Organization, The International 
Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. 
Sydney: Health Communications Australia; 2000. 
22. Oda E, Watanabe K. Japanese criteria of metabolic syndrome. Circ J 2006;70: 364. 
23. Pico F, Dufouil C, Lévy C et al. Longitudinal study of carotid atherosclerosis and 
white matter hyperintensities: The EVA-MRI Cohort. Cerebrovasc Dis 
2002;14:109-115. 
24. Kleinbaum DG, Klein M. Logistic Regression: A Self-Learning Text, 2nd ed. New 
York: Springer-Verlag; 2002. 
 Park-24
25. Longstreth WT, Manolio TA, Arnold A et al., Clinical correlates of white matter 
findings on cranial magnetic resonance imaging of 3301 elderly people. The 
Cardiovascular Health Study. Stroke 1996;27:1274-1282. 
